Trials / Sponsors / Kronos Bio
Kronos Bio
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | A Study to Evaluate Lanraplenib (LANRA) in Combination With Gilteritinib in Participants With FLT3-mutated Rel Acute Myeloid Leukemia, Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 / Phase 2 | 2022-08-05 |
| Terminated | Entospletinib Plus Intensive Induction/Consolidation Chemotherapy in Newly Diagnosed NPM1-mutated AML Nucleophosmin 1-mutated Acute Myeloid Leukemia | Phase 3 | 2021-11-24 |
| Terminated | A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Relapsed Solid Tumors, Refractory Solid Tumors, Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2021-02-08 |